Dolutegravir is an antiretroviral medication belonging to the integrase strand transfer inhibitor (INSTI) class, used in combination therapy to treat HIV-1 infection by blocking the viral integration process… Read more









![Chemical structure of Ethyl (4R,12aS)-7-bromo-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1246616-78-3-Ethyl-4R12aS-7-bromo-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazine-9-carboxylate.png&w=3840&q=75)
![Chemical structure of Ethyl (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2677842-37-2-Ethyl-4R12aS-7-hydroxy-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazine-9-carboxylate.png&w=3840&q=75)



![Chemical structure of N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1830380-29-4-N-24-Difluorobenzyl-7-hydroxy-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazine-9-carboxamide.png&w=3840&q=75)
![Chemical structure of N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2374716-73-9-N-24-Difluorobenzyl-9-hydroxy-2-4-hydroxybutan-2-yl-18-dioxo-18-dihydro-2H-pyrido12-apyrazine-7-carboxamide.png&w=3840&q=75)





![Chemical structure of rel-(4R,12aR)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2968897-85-8-rel-4R12aR-N-24-difluorobenzyl-7-methoxy-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazine-9-carboxamide.png&w=3840&q=75)
![Chemical structure of Sodium (4R,12aS)-9-((2-fluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-4R12aS-9-2-fluorobenzylcarbamoyl-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazin-7-olate.png&w=3840&q=75)
![Chemical structure of Sodium (4R,12aS)-9-((4-fluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-4R12aS-9-4-fluorobenzylcarbamoyl-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazin-7-olate.png&w=3840&q=75)
![Chemical structure of Sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1309575-43-6-Sodium-4S12aR-9-24-difluorobenzylcarbamoyl-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazin-7-olate.png&w=3840&q=75)
![Chemical structure of Sodium (4S,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-4S12aS-9-24-difluorobenzylcarbamoyl-4-methyl-68-dioxo-34681212a-hexahydro-2H-pyrido1245pyrazino21-b13oxazin-7-olate.png&w=3840&q=75)
![Chemical structure of Sodium (R)-7-((2,4-difluorobenzyl)carbamoyl)-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazin-9-olate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-R-7-24-difluorobenzylcarbamoyl-2-4-hydroxybutan-2-yl-18-dioxo-18-dihydro-2H-pyrido12-apyrazin-9-olate.png&w=3840&q=75)
Dolutegravir is an antiretroviral medication belonging to the integrase strand transfer inhibitor (INSTI) class, used in combination therapy to treat HIV-1 infection by blocking the viral integration process into host cell DNA. This category provides an extensive range of analytical reference materials, including impurities, metabolites, and stable isotope-labelled compounds, designed to support rigorous pharmaceutical analysis. Laboratories utilize these high-quality standards for impurity profiling, method development, and quality control testing to ensure compliance with global regulatory specifications. By providing critical components such as synthetic intermediates, degradation products, and structural analogs, these reference standards enable precise analytical method validation and forced degradation studies. These materials are essential for maintaining pharmaceutical consistency, verifying identity, and assessing purity throughout the drug development and manufacturing lifecycles.